Middle East & Africa Cancer Diagnostics Market Size & Outlook
Middle East & Africa cancer diagnostics market, 2018-2030 (US$M)
Related Markets
MEA cancer diagnostics market highlights
- The MEA cancer diagnostics market generated a revenue of USD 4,429.0 million in 2023.
- The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 4,429.0 million |
| Market revenue in 2030 | USD 6,577.9 million |
| Growth rate | 5.8% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.1% of the global cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 35,952.3 million by 2030.
Consumables was the largest segment with a revenue share of 59.99% in 2023. Horizon Databook has segmented the Middle East & Africa cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & Africa holds major growth opportunities, as a majority of the market is untapped due to the unavailability of organized cancer screening programs in this region, especially in underdeveloped African economies.
In the past few years, countries such as the UAE, Morocco, & South Africa have organized cancer screening programs. Collaborations of various companies with government institutes to supply these tests are also expected to boost the market.
These initiatives are anticipated to lead to the development of newer cancer detection tests. Novel cancer tests, including liquid biopsy, are expensive, thus, there is a shortage of experienced professionals to perform these tests.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA cancer diagnostics market size, by country, 2018-2030 (US$M)
Middle East & Africa Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
